Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ekaterina I. Ryabova
Observed names:
E Ryabova,
E. I. Ryabova,
E.I. Ryabova,
Ekaterina Ryabova,
Е. И. Рябова,
Е.И. Рябова,
Рябова Е. И.
show all 7
Institutions:
Gamalei Institute of Epidemiology and Microbiology,
Ministry of Health of the Russian Federation
Observed institutions:
Gamalei Institute of Epidemiology and Microbiology,
Ministry of Health of the Russian Federation,
Moscow State Academy of Veterinary Medicine and Biotechnology named after Skryabin
ORCID:
0000-0002-2687-5185
Observed ORCID:
0000-0002-2687-5185
OpenAlex ID:
A5041318535
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
2022
·
Irina A. Favorskaya
, Dmitry V. Shcheblyakov
, et al.
·
Frontiers in Immunology
·
38
PDF
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
2021
·
Ilias B. Esmagambetov
, Dmitriy V. Shcheblyakov
, et al.
·
Acta Naturae
·
22
PDF
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
2023
·
Ilias B. Esmagambetov
, Ekaterina I. Ryabova
, et al.
·
Frontiers in Immunology
·
17
PDF
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
2022
·
Artem A. Derkaev
, Ekaterina I. Ryabova
, et al.
·
Frontiers in Microbiology
·
17
PDF
Comparison of different technologies for producing recombinant adeno-associated virus on a laboratory scale
2021
·
E. I. Ryabova
, A. A. Derkaev
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
11
PDF
Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus
2024
·
D. V. Shcheblyakov
, D. V. Voronina
, et al.
·
Acta Naturae
·
8
Ultra-potent RBM-specific single-domain antibody broadly neutralizes multiple SARS-CoV-2 variants with picomolar activity
2025
·
Dmitry V. Shcheblyakov
, Irina A. Favorskaya
, et al.
·
International Journal of Biological Macromolecules
·
5
Development of technology for culturing a cell line producing a single-domain antibody fused with the Fc fragment of human IgG1
2024
·
D. S. Polyansky
, E. I. Ryabova
, et al.
·
Fine Chemical Technologies
·
5
PDF
A modified single-domain antibody candidate for the treatment of botulism caused by botulinum toxin type A
2025
·
A. A. Derkaev
, E. I. Ryabova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
4
PDF
Method for obtaining recombinant antibodies produced by a cell line transduced with recombinant adenoviruses
2023
·
E. S. Sedova
, D. N. Shcherbinin
, et al.
·
Fine Chemical Technologies
·
4
PDF
Preparation and Crystallographic Analysis of a Complex of SARS-CoV-2 S-Protein Receptor-Binding Domain with a Virus-Neutralizing Nanoantibody
2023
·
K. M. Boyko
, L. A. Varfolomeeva
, et al.
·
Crystallography Reports
·
3
Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19
2021
·
Anna S. Karyagina
, Alexander V. Gromov
, et al.
·
Biochemistry (Moscow)
·
3
PDF
Recombinant RBD of the SARS-CoV-2 Spike Protein: Production in Escherichia coli Cells, Binding to Antibodies, and Antiviral Activity
2023
·
M. S. Gromova
, A. V. Gromov
, et al.
·
Molecular Genetics Microbiology and Virology
·
2
Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies
2023
·
A. A. Derkaev
, E. I. Ryabova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
2
PDF
Risk assessment of germline transmission of adeno-associated virul vector of chimeric serotype PHP.eB into mouse oocytes
2026
·
A. D. Malikova
, A. K. Zhanataev
, et al.
·
Bulletin of Siberian Medicine
·
1
PDF
Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants
2026
·
Anastasia I. Korobkova
, Irina A. Favorskaya
, et al.
·
Frontiers in Immunology
·
1
PDF
Comparative analysis of three genetic constructs for delivery and expression of a modified single-domain antibody gene in rAAV
2026
·
E. I. Ryabova
, A. A. Derkaev
, et al.
·
Fine Chemical Technologies
·
1
PDF
rAAV‑mediated Hsp70 gene delivery alleviates FUS‑associated ALS‑like pathology
2026
·
Evgeny Bronovitsky
, Ilias Esmagambetov
, et al.
·
Research Square
Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates
2026
·
Ekaterina I. Ryabova
, Artem A. Derkaev
, et al.
·
Frontiers in Immunology
PDF
Structural basis of influenza A virus neutralization by broadly reactive single-domain antibody G2.3 recognizing glycosylated epitope within hemagglutinin stem domain
2026
·
Igor O. Ilyasov
, Daria V. Voronina
, et al.
·
International Journal of Biological Macromolecules
Development and scaling of a chromatographic purification technology for single-domain antibodies fused to the Fc fragment of human IgG1
2026
·
D. S. Polyansky
, V. V. Prokofiev
, et al.
·
Fine Chemical Technologies
PDF
Production and Structural-Functional Characterization of a Recombinant HIV-1 Env Trimer Based on the Consensus Sequence of the Most Prevalent Strains in the Russian Federation
2026
·
I. A. Favorskaya
, I. O. Ilyasov
, et al.
·
Russian Journal of Bioorganic Chemistry
Тест-системы для определения остаточных количеств ДНК и белков клеток хозяина для биофармацевтического производства
2025
·
М.В. Разумихин
, Е.И. Рябова
, et al.
·
ANALYTICS Russia
PDF
Кандидатный препарат на основе модифицированных однодоменных антител для терапии ботулизма, вызванного ботулиническим токсином типа А
2025
·
Деркаев А. А.
, Рябова Е. И.
, et al.
·
Biological Products Prevention Diagnosis Treatment
Development and Scaling of Cell Line Cultivation Technology Producing Modified Single-domain Antibodies
2025
·
D.S. Polyansky
, E.I. Ryabova
, et al.
·
Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов (OpenBio)
PDF
Show more works
View as search
Works count:
37
Citation count:
144
H-index:
6
I10-index:
5
Year
Topic
Type